In-Vitro Diagnostic Substance Manufacturing (NAICS 325413) Industry Market Research Report

In-Vitro Diagnostic Substance Manufacturing - Market Size and Forecast

The In-Vitro Diagnostic Substance Manufacturing report contains both historical and forecasted statistics. Total market size figures from 2015 to 2025 reveal industry growth patterns and trends. Market size measurementsincludes both public and private companies in the industry.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Market Size (Total Revenue)

Included

% Growth Rate
Number of Companies
Total Employees
Average Revenue per Company
Average Employees per Company
Source: U.S. government financial data.

Industry Revenue ($ Billions)

In-Vitro Diagnostic Substance Manufacturing Industry Revenue
  • 2015
  • 2016
  • 2017
  • 2018
  • 2019
  • 2020
  • 2021


Advanced econometric models forecast five years of industry growth based on short- and long-term trend analysis. Market size includes revenue generated from all products and services sold within the industry.

In-Vitro Diagnostic Substance Manufacturing - Geographic Breakdown by U.S. State

Market size by state reveals local opportunity through the number of companies located in the region. Each state's growth rate is affected by regional economic conditions. Data by state can be used to pinpoint profitable and nonprofitable locations for In-Vitro Diagnostic Substance Manufacturing companies in the United States.

In-Vitro Diagnostic Substance Manufacturing Revenue by State

US Market Size by State

Distribution by Company Size

Company Size All Industries In-Vitro Diagnostic Substance Manufacturing
Small Business (< 5 Employees)

Included

Small Business (5 - 20)
Midsized Business (20 - 100)
Large Business (100 - 500)
Enterprise (> 500)

In-Vitro Diagnostic Substance Manufacturing - Income Statement (Average Financial Metrics)

Financial statement analysis determines averages for the following industry forces:
The report includes a traditional income statement from an "average" company (both public and private companies included).

Industry Average Percent of Sales
Total Revenue

Included

Operating Revenue
Cost of Goods Sold (COGS)
Gross Profit
Operating Expenses
Operating Income
Non-Operating Income
Earnings Before Interest and Taxes (EBIT)
Interest Expense
Earnings Before Taxes
Income Tax
Net Profit


Average Income Statement

Average Income Statement

Cost of Goods Sold

Salaries, Wages, and Benefits

Rent

Advertising

Depreciation and Amortization

Officer Compensation

Net Income


In-Vitro Diagnostic Substance Manufacturing - Financial Ratio Analysis

Financial ratios allow a company's performance to be compared against that of its peers.

Financial RatioIndustry Average
Profitability Ratios

Included

Profit Margin
ROE
ROA
Liquidity Ratios
Current Ratio
Quick Ratio
Activity Ratios
Average Collection Period
Asset Turnover Ratio
Receivables Turnover Ratio
Inventory Conversion Ratio

In-Vitro Diagnostic Substance Manufacturing - Product Mix

Product Description Description Revenue
($ Millions)

In-vitro diagnostic substance manufacturing

Included

In-vitro diagnostic substances

In vitro diagnostic substances, nsk, total

In vitro diagnostic substances, nsk, administrative-records


In-Vitro Diagnostic Substance Manufacturing - Compensation and Salary Surveys

TitlePercent of Workforce Bottom Quartile Average (Median) Salary Upper Quartile
Management Occupations 11%

Included

Chief Executives 0%
General and Operations Managers 2%
Business and Financial Operations Occupations 8%
Business Operations Specialists 7%
Architecture and Engineering Occupations 6%
Life, Physical, and Social Science Occupations 16%
Life Scientists 6%
Physical Scientists 6%
Chemists and Materials Scientists 6%
Chemists 6%
Office and Administrative Support Occupations 8%
Production Occupations 32%
Other Production Occupations 26%
Packaging and Filling Machine Operators and Tenders 9%
Packaging and Filling Machine Operators and Tenders 9%

Government Contracts

In 2008, the federal government spent a total of $184,699,470 on the in-vitro diagnostic substance manufacturing industry. It has awarded 4,677 contracts to 256 companies, with an average value of $721,482 per company.

In-Vitro Diagnostic Substance Manufacturing and Adjacent Industries - Top Companies

Company Address Revenue
($ Millions)

Included





In-Vitro Diagnostic Substance Manufacturing Industry Report
Geography United States  
Publication Date July 2020
Report Format PDF Download  
Price $499

Related Market Research Reports

Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product Manufacturing